• Home

  • Documents

  • Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day...
45
Post Chicago 2012 Cancer du sein S. Sami, K. Bouzid. CPMC

Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years

Post Chicago 2012 Cancer du sein 

S. Sami, K. Bouzid. 

CPMC

Page 2: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 3: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 4: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 5: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 6: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 7: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 8: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 9: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 10: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 11: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 12: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 13: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 14: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 15: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 16: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 17: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 18: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 19: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 20: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 21: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 22: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 23: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 24: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 25: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 26: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 27: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 28: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 29: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 30: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 31: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 32: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 33: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 34: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 35: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 36: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 37: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 38: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 39: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 40: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 41: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 42: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 43: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 44: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years
Page 45: Cancer du sein - Santé tropicale · Postmenopausal ER*ve Early Breast Cancer Anastrozole 1 mg/day x 5 years n = 7576 patients May 2003 - Jul 2008 Exemestane 25 mg/day x 5 years

Merci de votre attention


Arimidex (anastrozole) tablet label

Arimidex (anastrozole) tablet label

Documents
Code Product Unit - Эколан · 100 mg 10 mg 0.06 mg 50 mg 50 mg 100 mg 0.0068 mg 50 mg 50 mg 10 mg 10 mg 50 mg 10 mg 15 mg 0.002 mg 125 mg 200 mg 1 mL 75 mg 10 mg 0.3 mg 0.004

Code Product Unit - Эколан · 100 mg 10 mg 0.06 mg 50 mg 50 mg 100 mg 0.0068 mg 50 mg 50 mg 10 mg 10 mg 50 mg 10 mg 15 mg 0.002 mg 125 mg 200 mg 1 mL 75 mg 10 mg 0.3 mg 0.004

Documents
Anastrozole 1 mg Film-coated Tablets PL 18727/0014 · version of Arimidex 1 mg Film-coated Tablets ... Anastrozole is a white to off-white crystalline ... Anastrozole 1 mg Film-coated

Anastrozole 1 mg Film-coated Tablets PL 18727/0014 · version of Arimidex 1 mg Film-coated Tablets ... Anastrozole is a white to off-white crystalline ... Anastrozole 1 mg Film-coated

Documents
Why I choose Everolimus + Exemestane (BOLERO2) after progression on endocrine therapy in HR+ MBC

Why I choose Everolimus + Exemestane (BOLERO2) after progression on endocrine therapy in HR+ MBC

Health & Medicine
Metastatic HR+, TNBC, & Bisphosphonates Abstracts SABCS Rev 01...SABCS 2009 (FACT) 514 Anastrozole (38.2) Anastrozole + Fulvestrant (37.8) 1.00 1.00 Nabholtz 2003 Eur J C 1021 Tamoxifen

Metastatic HR+, TNBC, & Bisphosphonates Abstracts SABCS Rev 01...SABCS 2009 (FACT) 514 Anastrozole (38.2) Anastrozole + Fulvestrant (37.8) 1.00 1.00 Nabholtz 2003 Eur J C 1021 Tamoxifen

Documents
PRODUCT MONOGRAPH - Auro Pharma · PRODUCT MONOGRAPH . Pr. AURO-ANASTROZOLE (anastrozole) 1 mg tablet . Non-Steroidal Aromatase Inhibitor . Auro Pharma Inc. 3700 Steeles Avenue West,

PRODUCT MONOGRAPH - Auro Pharma · PRODUCT MONOGRAPH . Pr. AURO-ANASTROZOLE (anastrozole) 1 mg tablet . Non-Steroidal Aromatase Inhibitor . Auro Pharma Inc. 3700 Steeles Avenue West,

Documents
TABLETS - Stokes PharmacyMighty Bites.. 80 mg 150 mg Famciclovir Mini-Meds 31.25 mg 62.5 mg Fludrocortisone Mini-Meds 0.15 mg 0.25 mg 0.3 mg 0.4 mg 0.5 mg 0.6 mg 0.7 mg Fluoxetine

TABLETS - Stokes PharmacyMighty Bites.. 80 mg 150 mg Famciclovir Mini-Meds 31.25 mg 62.5 mg Fludrocortisone Mini-Meds 0.15 mg 0.25 mg 0.3 mg 0.4 mg 0.5 mg 0.6 mg 0.7 mg Fluoxetine

Documents
Subcutaneous Testosterone-Anastrozole Therapy in … · Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca

Subcutaneous Testosterone-Anastrozole Therapy in … · Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca

Documents
Subcutaneous Testosterone-Anastrozole Therapy in Breast

Subcutaneous Testosterone-Anastrozole Therapy in Breast

Documents
China Anastrozole Industry 2015 - Size, Share, Demand, Growth & Opportuniti

China Anastrozole Industry 2015 - Size, Share, Demand, Growth & Opportuniti

Documents
onac.org.co · 2019. 11. 20. · 0,001 5 mg 0.0023 mg 0,0036 mg 0,0047 mg 0,0042 mg 0,0019 mg 00032 mg 0,0047 mg 0,0042 mg 0,0089 mg 0.013 mg 0,029 mg 0.049 mg 0,073 mg 0.21 mg 0,43

onac.org.co · 2019. 11. 20. · 0,001 5 mg 0.0023 mg 0,0036 mg 0,0047 mg 0,0042 mg 0,0019 mg 00032 mg 0,0047 mg 0,0042 mg 0,0089 mg 0.013 mg 0,029 mg 0.049 mg 0,073 mg 0.21 mg 0,43

Documents
Everolimus Plus Exemestane in Postmenopausal · PDF fileORIGINAL RESEARCH Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free

Everolimus Plus Exemestane in Postmenopausal · PDF fileORIGINAL RESEARCH Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free

Documents
INTERGROUP EXEMESTANE STUDY Updated survival analysis … · INTERGROUP EXEMESTANE STUDY Updated survival analysis R Charles Coombes, Emma Hall, Claire F Snowdon, Lesley Fallowfield,

INTERGROUP EXEMESTANE STUDY Updated survival analysis … · INTERGROUP EXEMESTANE STUDY Updated survival analysis R Charles Coombes, Emma Hall, Claire F Snowdon, Lesley Fallowfield,

Documents
Presentazione standard di PowerPoint - OverGroupStudy design Up-front vs sequential treatment analysis Anastrozole vs Exemestane vs Letrozole analysis R A N D O M I Z E. Baseline characteristics

Presentazione standard di PowerPoint - OverGroupStudy design Up-front vs sequential treatment analysis Anastrozole vs Exemestane vs Letrozole analysis R A N D O M I Z E. Baseline characteristics

Documents
Extended Hormonal Therapy - Provincial Health Services ...learn.phsa.ca/bcca/fpon/07HormonalTherapiesLohrisch.pdf · ANASTROZOLE (ARIMIDEX) LETROZOLE (FEMARA) EXEMESTANE (AROMASIN)

Extended Hormonal Therapy - Provincial Health Services ...learn.phsa.ca/bcca/fpon/07HormonalTherapiesLohrisch.pdf · ANASTROZOLE (ARIMIDEX) LETROZOLE (FEMARA) EXEMESTANE (AROMASIN)

Documents
Anastrozole mediated modulation of mitochondrial …1 Anastrozole mediated modulation of mitochondrial activity by inhibition of mitochondrial permeability transition pore opening:

Anastrozole mediated modulation of mitochondrial …1 Anastrozole mediated modulation of mitochondrial activity by inhibition of mitochondrial permeability transition pore opening:

Documents
HORMONOTERAPIA NEOADYUVANTE Anastrozole vs Tamoxifeno

HORMONOTERAPIA NEOADYUVANTE Anastrozole vs Tamoxifeno

Documents
Exemestane 25 mg Film-Coated Tablets - PL 20117/0198

Exemestane 25 mg Film-Coated Tablets - PL 20117/0198

Documents
Rabakir 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 300 mg

Rabakir 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 300 mg

Documents
A Comparison of Fulvestrant 500 mg with Anastrozole as First-line Treatment for Advanced Breast Cancer: Follow-up Analysis from the FIRST Study Robertson

A Comparison of Fulvestrant 500 mg with Anastrozole as First-line Treatment for Advanced Breast Cancer: Follow-up Analysis from the FIRST Study Robertson

Documents
Breast Cancer Treatment With Everolimus and Exemestane for ER … › NOVPDF › ESMO-Poster-Fasching.pdf · 2014-10-07 · Breast Cancer Treatment With Everolimus and Exemestane

Breast Cancer Treatment With Everolimus and Exemestane for ER … › NOVPDF › ESMO-Poster-Fasching.pdf · 2014-10-07 · Breast Cancer Treatment With Everolimus and Exemestane

Documents
16 mg / 12.5 mg, 32 mg / 12.5 mg and 32 mg / 25 mg

16 mg / 12.5 mg, 32 mg / 12.5 mg and 32 mg / 25 mg

Documents
Adjuvant Exemestane with Ovarian Suppression in ... · PDF file01.06.2014 · Adjuvant Exemestane in Premenopausal Breast Cancer n engl j med nejm.org 3 torelin, bilateral oophorectomy,

Adjuvant Exemestane with Ovarian Suppression in ... · PDF file01.06.2014 · Adjuvant Exemestane in Premenopausal Breast Cancer n engl j med nejm.org 3 torelin, bilateral oophorectomy,

Documents
Metadate CD (methylphenidate HCl, USP) Extended-Release ... · mg (6 mg IR; 14 mg ER), 30 mg (9 mg IR; 21 mg ER), 40 mg (12 mg IR; 28 mg ER), 50 mg (15 mg IR; 35 mg ER), or 60 mg

Metadate CD (methylphenidate HCl, USP) Extended-Release ... · mg (6 mg IR; 14 mg ER), 30 mg (9 mg IR; 21 mg ER), 40 mg (12 mg IR; 28 mg ER), 50 mg (15 mg IR; 35 mg ER), or 60 mg

Documents
Tamoxifen, Raloxifene , and Exemestane in the Chemoprevention of Breast Cancer

Tamoxifen, Raloxifene , and Exemestane in the Chemoprevention of Breast Cancer

Documents
Exemestane 25 mg film-coated tablets PL 24668/0260 · MHRA PAR; EXEMESTANE 25 MG FILM-COATED TABLETS, PL 24668/0260 4 INTRODUCTION Based on the review of the data on …

Exemestane 25 mg film-coated tablets PL 24668/0260 · MHRA PAR; EXEMESTANE 25 MG FILM-COATED TABLETS, PL 24668/0260 4 INTRODUCTION Based on the review of the data on …

Documents
Subcutaneous Testosterone-Anastrozole Therapy in … ppt.pdf · Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract

Subcutaneous Testosterone-Anastrozole Therapy in … ppt.pdf · Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract

Documents
ioni.pom.go.idioni.pom.go.id/sites/default/files/obat_baru/Aromasin Tablet salut gula... · The recommended dose of Exemestane is one 25 mg tablet to be taken once daily, preferably

ioni.pom.go.idioni.pom.go.id/sites/default/files/obat_baru/Aromasin Tablet salut gula... · The recommended dose of Exemestane is one 25 mg tablet to be taken once daily, preferably

Documents
AROMASIN® (exemestane): Adjuvant Therapy for Early Stage

AROMASIN® (exemestane): Adjuvant Therapy for Early Stage

Documents
ARIMIDEX® - Food and Drug Administration · NDA 20-541/S-016 Page 4 09-15-05 ARIMIDEX® Anastrozole TABLETS DESCRIPTION ARIMIDEX® (anastrozole) tablets for oral administration contain

ARIMIDEX® - Food and Drug Administration · NDA 20-541/S-016 Page 4 09-15-05 ARIMIDEX® Anastrozole TABLETS DESCRIPTION ARIMIDEX® (anastrozole) tablets for oral administration contain

Documents